Alzamend Neuro Stock Price, News & Analysis
ALZN
NASDAQ
Company Description
Welcome to the overview page for Alzamend Neuro (ALZN), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
Insider Radar
Net Sellers
90-Day Summary
0
Shares Bought
772,734
Shares Sold
16
Transactions
Most Recent Transaction
McGrath Lynne Fahey
(Director)
sold
30 shares
@ $2.29
on Oct 23, 2025
Based on SEC Form 4 filings over the last 90 days.
Financial Highlights
$0
Revenue (TTM)
-$1,039,434
Net Income (TTM)
-$0.19
-$1,423,638
Operating Cash Flow
5.44
-$1,037,415
Upcoming Events
DEC
31
December 31, 2025
Clinical
Topline data release
Topline data for Phase II AL001 ‘Lithium in Brain’ study due
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Alzamend Neuro (ALZN)?
The current stock price of Alzamend Neuro (ALZN) is $2.02 as of December 26, 2025.
What is the market cap of Alzamend Neuro (ALZN)?
The market cap of Alzamend Neuro (ALZN) is approximately 7.8M. Learn more about what market capitalization means .
What is the revenue (TTM) of Alzamend Neuro (ALZN) stock?
The trailing twelve months (TTM) revenue of Alzamend Neuro (ALZN) is $0.
What is the net income of Alzamend Neuro (ALZN)?
The trailing twelve months (TTM) net income of Alzamend Neuro (ALZN) is -$1,039,434.
What is the earnings per share (EPS) of Alzamend Neuro (ALZN)?
The diluted earnings per share (EPS) of Alzamend Neuro (ALZN) is -$0.19 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of Alzamend Neuro (ALZN)?
The operating cash flow of Alzamend Neuro (ALZN) is -$1,423,638. Learn about cash flow.
What is the current ratio of Alzamend Neuro (ALZN)?
The current ratio of Alzamend Neuro (ALZN) is 5.44, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of Alzamend Neuro (ALZN)?
The operating income of Alzamend Neuro (ALZN) is -$1,037,415. Learn about operating income.